Table 2

Clinical and healthcare resource use outcomes for the FPE and non-FPE groups

OutcomeFPE (n=91)Non-FPE (n=81)P value*
Clinical outcomes
90-Day mRS score (categorized into good and excellent functional outcomes)†
 Good outcomes (mRS score 0–2), n (%)70 (80.46%)47 (61.04%)<0.01
 Excellent outcomes (mRS score 0–1), n (%)55 (63.22%)36 (46.75%)0.03
90-Day mortality,‡ n (%)5 (5.68%)11 (13.75%)0.08
sICH within 24 hours, n (%)2 (2.20%)4 (4.94%)0.42
ENT, n (%)2 (2.20%)9 (11.11%)0.03
Healthcare resource use outcomes
 Total LOS, mean (IQR)§6.10 (3.00–8.00)9.48 (3.00–11.00)<0.01
 Standard bed days, mean (IQR)¶3.05 (0.00–5.00)6.13 (1.00–8.00)<0.01
 ICU days, mean (IQR)**3.39 (2.00–4.00)3.58 (2.00–4.00)0.70
  • *P values presented for the following tests: t-test or Wilcoxon rank-sum (Mann-Whitney) test for continuous variables and chi-square or Fisher’s exact test for categorical variables.

  • †Eight patients missing data for 90-day mRS score.

  • ‡Four patients missing data for 90-day mortality.

  • §Represents the date of discharge minus date of admission to study hospital; seven patients missing data for LOS.

  • ¶Represents the normal ward days; 10 patients missing data for standard bed days.

  • **Eight patients missing data for ICU days.

  • ENT, embolization into new territory; FPE, first-pass effect; ICU, intensive care unit; IQR, interquartile range; LOS, length of stay; mRS, modified Rankin Scale; NA, not applicable; sICH, symptomatic intracerebral hemorrhage.